Development Pipeline

We are pursuing a broad and deep pipeline that with the potential to address 80 percent of the world’s cancers by cancer type. In addition to leveraging our internal research resources, we continually evaluate external pre-clinical and early-stage assets that might expand our pipeline and contribute to our durable competitive advantages.

A pipeline refers to the drug development projects under research and development (R&D). Detailed information about the pipeline substances and clinical trials being conducted in our company can be found on the Global BeiGene website.

By accessing the website of BeiGene Australia(, you may be directed to other websites located outside of Australia. Access to and use of such sites and content are subject to separate terms and the laws of countries outside of Australia, as determined by those sites. To the maximum extent permitted by Australian law You assume all responsibility for accessing and using such sites.

You will be redirected to

Click the link above to continue or CANCEL